+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of biphasic insulin aspart and human insulin including biphasic human insulin in children with type 1 diabetes A safety and efficacy Trial



Comparison of biphasic insulin aspart and human insulin including biphasic human insulin in children with type 1 diabetes A safety and efficacy Trial



Diabetes & Metabolism 29(Hors serie 2): 4S227




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034618040

Download citation: RISBibTeXText


Related references

Comparison of biphasic insulin aspart and human insulin including biphasic human insulin in adolescents with type 1 diabetes A safety and efficacy Trial. Diabetes 52(Suppl. 1): A564, 2003

Safety and efficacy of long term exposure to biphasic insulin aspart compared with biphasic human insulin in people with type 2 diabetes. Diabetologia 46(Suppl. 2): A 269, 2003

Safety and efficacy of biphasic insulin aspart 30 in type 2 diabetes patients switched from either biphasic or basal human insulin: results from the Gulf cohort of the A1 chieve study. International Journal of Clinical Practice 68(7): 850-856, 2016

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes. Diabetes Care 25(5): 883-888, 2002

Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial. Diabetes, Obesity and Metabolism 2019, 2019

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin. Journal of Diabetes & its Complications 17(6): 307-313, November-December, 2003

A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study. Diabetes Technology and Therapeutics 14(7): 589-595, 2012

A randomised, multicentre trial of biphasic insulin aspart versus biphasic human insulin in Type 2 diabetes. Diabetologia 46(Suppl. 2): A 270, 2003

Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial. Diabetes Care 37(8): 2084-2090, 2015

Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Filipino cohort of the A₁chieve study. Diabetes Research and Clinical Practice 100 Suppl 1: S35-S40, 2013

Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Indonesian cohort of the A₁chieve study. Diabetes Research and Clinical Practice 100 Suppl 1: S41-S46, 2013

Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: results from the A₁chieve study. Diabetes Research and Clinical Practice 98(3): 408-413, 2013

Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan. Diabetes Research and Clinical Practice 135: 218-226, 2017

28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes. Journal of Diabetes Investigation 1(3): 103-110, 2010

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature. Indian Journal of Endocrinology and Metabolism 20(3): 288-299, 2016